{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:38:31Z","timestamp":1773297511095,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.bbrc.2019.09.082","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T16:40:02Z","timestamp":1569861602000},"page":"93-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["H1, a derivative of tetrandrine, enhances the efficacy of 5-FU in Bel7402\/5-FU cells via suppressing STAT3\/MCL-1 and inducing PUMA"],"prefix":"10.1016","volume":"520","author":[{"given":"Fengli","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2723-4061","authenticated-orcid":false,"given":"Ning","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2019.09.082_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bbrc.2019.09.082_bib2","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1053\/j.gastro.2015.05.061","article-title":"Genetic landscape and biomarkers of hepatocellular carcinoma","volume":"149","author":"Zucman-Rossi","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2019.09.082_bib3","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2019.09.082_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijid.2017.09.003","article-title":"Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: experience of the Chinese National Cancer Center","volume":"65","author":"Wang","year":"2017","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.bbrc.2019.09.082_bib5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2019.09.082_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0026-895X(25)10875-4","article-title":"Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines","volume":"39","author":"Chu","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2019.09.082_bib7","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/0959-8049(94)00216-R","article-title":"A\u00a0role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil","volume":"30A","author":"Beck","year":"1994","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbrc.2019.09.082_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ijc.11176","article-title":"Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines","volume":"106","author":"Arnold","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2019.09.082_bib9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000065068","article-title":"Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes","volume":"62","author":"Shi","year":"2002","journal-title":"Oncology"},{"key":"10.1016\/j.bbrc.2019.09.082_bib10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s10120-012-0153-6","article-title":"Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells","volume":"16","author":"Akagi","year":"2013","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.bbrc.2019.09.082_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/carcin\/bgy135","article-title":"STAT3- and GSK3beta-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma","volume":"40","author":"Maji","year":"2019","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrc.2019.09.082_bib12","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/ijc.28429","article-title":"STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in\u00a0vitro and in\u00a0vivo","volume":"134","author":"Spitzner","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2019.09.082_bib13","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.bcp.2011.08.012","article-title":"H1, a derivative of Tetrandrine, exerts anti-MDR activity by initiating intrinsic apoptosis pathway and inhibiting the activation of Erk1\/2 and Akt1\/2","volume":"82","author":"Wei","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2019.09.082_bib14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00280-010-1397-7","article-title":"H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein","volume":"67","author":"Wei","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbrc.2019.09.082_bib15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/15384047.2015.1040950","article-title":"Inhibition of AKT\/FoxO3a signaling induced PUMA expression in response to p53-independent cytotoxic effects of H1: a derivative of tetrandrine","volume":"16","author":"Zhang","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bbrc.2019.09.082_bib16","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1021\/jm9604080","article-title":"Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells","volume":"39","author":"Ojima","year":"1996","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.bbrc.2019.09.082_bib17","article-title":"S9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton","volume":"4","author":"Zhang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2019.09.082_bib18","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1158\/1078-0432.CCR-08-0550","article-title":"N-(2,6-dimethoxypyridine-3-yl)-9-methylcarbazole-3-sulfonamide as a novel tubulin ligand against human cancer","volume":"14","author":"Wang","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2019.09.082_bib19","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2019.09.082_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ccr.2014.05.019","article-title":"Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cells","volume":"26","author":"Lee","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2019.09.082_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pharmthera.2014.08.003","article-title":"Small molecule Mcl-1 inhibitors for the treatment of cancer","volume":"145","author":"Belmar","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2019.09.082_bib22","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1158\/1078-0432.CCR-17-1574","article-title":"Overcoming acquired resistance to AZD9291, a third-generation EGFR inhibitor, through modulation of MEK\/ERK-dependent Bim and Mcl-1 degradation","volume":"23","author":"Shi","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2019.09.082_bib23","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/onc.2009.45","article-title":"PUMA, a potent killer with or without p53","volume":"27","author":"Yu","year":"2008","journal-title":"Oncogene"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19318157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19318157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:43:08Z","timestamp":1757763788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X19318157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0006291X19318157"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.09.082","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"H1, a derivative of tetrandrine, enhances the efficacy of 5-FU in Bel7402\/5-FU cells via suppressing STAT3\/MCL-1 and inducing PUMA","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.09.082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}